List of most profitable companies in Biotechnology & Pharmaceuticals Industry over the past 12 months
|
Company |
12 Months Ending from the most recent quarter |
Net Income In millions $ |
Net Income Margin |
Gross Profit Margin |
ROE |
Gilead Sciences Inc |
1 Q |
$
5,965.00 |
20.76% |
78.29% |
31.85% |
Amgen Inc |
4 Q |
$
4,090.00 |
12.24% |
61.53% |
67.18% |
Inhibrx Biosciences Inc |
1 Q |
$
1,722.97 |
- |
- |
1101.19% |
Exelixis Inc |
1 Q |
$
1,481.63 |
64.45% |
96.78% |
67.57% |
Biogen Inc |
1 Q |
$
1,479.30 |
15.07% |
75.58% |
8.97% |
Biontech Se |
4 Q |
$
1,041.94 |
24.36% |
84.29% |
4.6% |
Halozyme Therapeutics Inc |
1 Q |
$
485.36 |
44.76% |
83.45% |
122.24% |
Novavax inc |
1 Q |
$
478.70 |
38.14% |
87.44% |
- |
Neurocrine Biosciences Inc |
1 Q |
$
305.80 |
12.68% |
98.52% |
11.81% |
Adma Biologics Inc |
1 Q |
$
240.11 |
46.94% |
54.06% |
84.06% |
Bluebird Bio Inc |
1 Q |
$
139.44 |
- |
27.12% |
- |
Krystal Biotech Inc |
1 Q |
$
123.96 |
37.18% |
- |
13.56% |
Bio techne Corp |
1 Q |
$
110.51 |
9.07% |
65.44% |
5.32% |
Qiagen N v |
4 Q |
$
83.59 |
4.36% |
50.4% |
2.34% |
Gamida Cell Ltd |
1 Q |
$
79.38 |
- |
- |
- |
Engene Holdings Inc |
4 Q |
$
69.05 |
- |
- |
27.73% |
Outlook Therapeutics Inc |
1 Q |
$
21.12 |
- |
- |
- |
Pharmacyte Biotech Inc |
4 Q |
$
17.97 |
- |
- |
45.2% |
X4 Pharmaceuticals Inc |
1 Q |
$
14.60 |
46.54% |
82.42% |
29.32% |
Entera Bio Ltd |
1 Q |
$
9.73 |
- |
- |
90.98% |
Biomx Inc |
1 Q |
$
8.06 |
- |
- |
28.29% |
Precision Biosciences Inc |
4 Q |
$
7.17 |
10.43% |
- |
12.29% |
Scinai Immunotherapeutics Ltd |
4 Q |
$
6.50 |
- |
- |
- |
Champions Oncology Inc |
4 Q |
$
6.43 |
10.97% |
51.58% |
656.65% |
Monte Rosa Therapeutics Inc |
1 Q |
$
6.15 |
3.86% |
- |
2.65% |
Tracon Pharmaceuticals Inc |
2 Q |
$
5.20 |
46.68% |
- |
- |
Black Diamond Therapeutics Inc |
1 Q |
$
5.09 |
- |
- |
4.7% |
Protalix Biotherapeutics inc |
1 Q |
$
3.91 |
6.54% |
49.97% |
10.46% |
Vericel Corporation |
1 Q |
$
2.98 |
1.25% |
72.54% |
1.09% |
Futuretech Ii Acquisition Corp |
3 Q |
$
0.57 |
- |
- |
- |
Alvotech |
4 Q |
$
0.00 |
- |
- |
- |
Exozymes Inc |
4 Q |
$
0.00 |
- |
- |
- |
Fennec Pharmaceuticals Inc |
1 Q |
$
0.00 |
- |
- |
- |
Liminatus Pharma Inc |
1 Q |
$
0.00 |
- |
- |
- |
Silexion Therapeutics Corp |
1 Q |
$
0.00 |
- |
- |
- |
Vivosim Labs Inc |
1 Q |
$
0.00 |
- |
- |
- |
Green Planet Bioengineering Co Ltd |
1 Q |
$
-0.04 |
- |
- |
- |
Qrons Inc |
4 Q |
$
-0.06 |
- |
- |
- |
Enzon Pharmaceuticals inc |
1 Q |
$
-0.07 |
-3.83% |
- |
-2.45% |
Agentix Corp |
4 Q |
$
-0.39 |
- |
- |
- |
Armata Pharmaceuticals Inc |
1 Q |
$
-0.43 |
-9.41% |
- |
- |
Mosaic Immunoengineering Inc |
1 Q |
$
-0.81 |
- |
- |
- |
10x Capital Venture Acquisition Corp Iii |
3 Q |
$
-1.25 |
- |
- |
- |
Tc Biopharm holdings Plc |
1 Q |
$
-1.39 |
-36.15% |
- |
-149.66% |
Ladrx Corporation |
4 Q |
$
-1.59 |
- |
- |
- |
Peak Bio Inc |
3 Q |
$
-3.32 |
- |
- |
- |
Titan Pharmaceuticals Inc |
1 Q |
$
-4.21 |
- |
- |
-145.87% |
Zeo Scientifix Inc |
1 Q |
$
-4.90 |
-107.13% |
81.46% |
- |
Atlantic Coastal Acquisition Corp Ii |
1 Q |
$
-5.61 |
- |
- |
- |
Fresh Tracks Therapeutics Inc |
4 Q |
$
-5.69 |
-82.01% |
- |
-58.8% |
Dyadic International Inc |
1 Q |
$
-5.83 |
-163.94% |
66.88% |
-233.69% |
Creative Medical Technology Holdings Inc |
1 Q |
$
-6.09 |
-5926.81% |
46.73% |
-85.26% |
Tradeup Acquisition Corp |
1 Q |
$
-6.96 |
- |
- |
-107.91% |
Channel Therapeutics Corporation |
1 Q |
$
-7.36 |
- |
- |
- |
Redwoods Acquisition Corp |
1 Q |
$
-8.26 |
- |
- |
-1906.53% |
Biocardia Inc |
1 Q |
$
-8.39 |
-633.28% |
- |
-30792.66% |
Innate Pharma Sa |
4 Q |
$
-8.48 |
-12.28% |
- |
-14.59% |
Mink Therapeutics Inc |
1 Q |
$
-9.74 |
- |
- |
- |
Coeptis Therapeutics Holdings Inc |
1 Q |
$
-9.87 |
- |
- |
-246.71% |
Genenta Science S p a |
4 Q |
$
-9.98 |
- |
- |
-71.32% |
Phoenix Biotech Acquisition Corp |
1 Q |
$
-10.04 |
- |
- |
- |
Tevogen Bio Holdings Inc |
4 Q |
$
-10.27 |
- |
- |
- |
Brainstorm Cell Therapeutics inc |
1 Q |
$
-11.09 |
- |
- |
- |
Finch Therapeutics Group Inc |
2 Q |
$
-12.58 |
-2048.05% |
- |
-61.37% |
Palisade Bio Inc |
1 Q |
$
-13.14 |
- |
- |
-178.91% |
Cyclo Therapeutics Inc |
3 Q |
$
-13.26 |
-1523.26% |
85.49% |
- |
Compugen Ltd |
4 Q |
$
-14.23 |
-51.07% |
71.54% |
-25.92% |
Mymetics Corporation |
3 Q |
$
-14.31 |
-1164.71% |
- |
- |
Quince Therapeutics Inc |
1 Q |
$
-15.09 |
- |
- |
-42.91% |
Atara Biotherapeutics Inc |
1 Q |
$
-15.64 |
-5.16% |
- |
- |
Zivo Bioscience Inc |
1 Q |
$
-15.99 |
-25240.08% |
38.05% |
- |
Enzo Biochem Inc |
3 Q |
$
-16.07 |
-52.54% |
45.58% |
-24.56% |
Windtree Therapeutics Inc |
1 Q |
$
-16.13 |
-2206.57% |
- |
-228.88% |
Lineage Cell Therapeutics Inc |
1 Q |
$
-16.17 |
-169.16% |
97.15% |
-22.58% |
Intensity Therapeutics Inc |
1 Q |
$
-16.43 |
- |
- |
-361.58% |
Xtant Medical Holdings Inc |
4 Q |
$
-16.45 |
-14.03% |
58.2% |
-36.28% |
Aim Immunotech Inc |
4 Q |
$
-17.32 |
-10188.24% |
81.76% |
-553.44% |
Artiva Biotherapeutics Inc |
1 Q |
$
-20.31 |
- |
- |
-22.24% |
Pluri Inc |
1 Q |
$
-20.87 |
-2068.48% |
51.34% |
- |
Aptose Biosciences Inc |
1 Q |
$
-21.33 |
- |
- |
- |
Cardiol Therapeutics inc |
4 Q |
$
-21.55 |
- |
- |
-99.58% |
Immunocore Holdings Plc |
1 Q |
$
-21.63 |
-6.48% |
99.01% |
-5.86% |
Century Therapeutics inc |
1 Q |
$
-21.94 |
-19.1% |
- |
-10.71% |
Evaxion Biotech A |
4 Q |
$
-22.13 |
-30308.22% |
- |
- |
Calidi Biotherapeutics Inc |
4 Q |
$
-22.21 |
- |
- |
- |
Repligen Corp |
1 Q |
$
-22.98 |
-3.53% |
44.37% |
-1.15% |
Kiromic Biopharma Inc |
4 Q |
$
-26.90 |
- |
- |
- |
Cel sci Corporation |
4 Q |
$
-27.28 |
- |
- |
-232.43% |
In8bio Inc |
1 Q |
$
-27.43 |
- |
- |
-216.95% |
Denali Therapeutics Inc |
1 Q |
$
-31.24 |
-28.22% |
- |
-2.47% |
Miromatrix Medical inc |
3 Q |
$
-32.05 |
-2695.74% |
57.95% |
-140.89% |
Eloxx Pharmaceuticals Inc |
3 Q |
$
-32.10 |
- |
- |
- |
Genfit S a |
4 Q |
$
-32.36 |
-75.69% |
- |
-42.52% |
Cognition Therapeutics inc |
1 Q |
$
-33.30 |
- |
- |
-194.42% |
Sab Biotherapeutics Inc |
1 Q |
$
-34.28 |
-58.38% |
- |
-105.14% |
Inhibikase Therapeutics Inc |
1 Q |
$
-36.55 |
-59123.53% |
- |
-78.96% |
Candel Therapeutics Inc |
1 Q |
$
-39.58 |
-127667.74% |
- |
-136.74% |
Elutia Inc |
1 Q |
$
-39.89 |
-171.04% |
44.26% |
- |
Inmune Bio Inc |
1 Q |
$
-40.80 |
-11459.55% |
- |
-119.35% |
Aceragen Inc |
1 Q |
$
-41.05 |
- |
- |
-215.27% |
Ikena Oncology Inc |
1 Q |
$
-41.71 |
-137.27% |
- |
-32% |
Curis Inc |
1 Q |
$
-42.13 |
-376.08% |
- |
- |
Protara Therapeutics Inc |
1 Q |
$
-44.60 |
- |
- |
-42.68% |
Anavex Life Sciences Corp |
1 Q |
$
-47.14 |
-1081.19% |
-106.82% |
-40.93% |
Lenz Therapeutics Inc |
1 Q |
$
-47.74 |
- |
- |
-23.74% |
Elevation Oncology inc |
1 Q |
$
-47.99 |
- |
- |
-74.68% |
Axcella Health Inc |
2 Q |
$
-48.23 |
- |
- |
- |
Cardiff Oncology Inc |
1 Q |
$
-48.85 |
-1831.11% |
-12.71% |
-76.45% |
Aligos Therapeutics Inc |
1 Q |
$
-53.26 |
-1628.75% |
- |
-104.02% |
Biocryst Pharmaceuticals Inc |
1 Q |
$
-53.47 |
-10.62% |
96.91% |
- |
Senti Biosciences Inc |
1 Q |
$
-54.79 |
-1063.7% |
- |
-177.25% |
Compass Therapeutics Inc |
1 Q |
$
-55.22 |
- |
- |
-42.48% |
Ocugen Inc |
1 Q |
$
-57.44 |
-1270.15% |
- |
-222.83% |
Vaxart Inc |
1 Q |
$
-58.12 |
-122.63% |
- |
-91.89% |
Allovir Inc |
4 Q |
$
-58.77 |
- |
- |
-49.47% |
Poseida Therapeutics Inc |
3 Q |
$
-60.76 |
-40.28% |
- |
-72.26% |
Bioatla Inc |
1 Q |
$
-61.88 |
- |
- |
-357.92% |
Molecular Partners Ag |
4 Q |
$
-61.98 |
-880.7% |
- |
-35.13% |
Zura Bio Limited |
1 Q |
$
-62.10 |
- |
- |
-41.35% |
Acorda Therapeutics Inc |
1 Q |
$
-62.49 |
-62.53% |
86.6% |
-1387.54% |
Turnstone Biologics Corp |
1 Q |
$
-63.01 |
- |
- |
-162.8% |
Passage Bio Inc |
1 Q |
$
-63.46 |
- |
- |
-93.59% |
Atyr Pharma Inc |
4 Q |
$
-64.02 |
- |
- |
-85.17% |
Tectonic Therapeutic Inc |
1 Q |
$
-67.08 |
- |
- |
-35.37% |
Sqz Biotechnologies Company |
3 Q |
$
-69.27 |
-331.93% |
- |
-223.95% |
Achilles Therapeutics Plc |
4 Q |
$
-69.67 |
- |
- |
-48.93% |
Adaptimmune Therapeutics Plc |
1 Q |
$
-69.90 |
-38.52% |
97.74% |
-185.54% |
Nkgen Biotech Inc |
3 Q |
$
-72.69 |
- |
- |
- |
Orchard Therapeutics Plc |
3 Q |
$
-72.92 |
-333.9% |
69.17% |
-74.94% |
Omega Therapeutics Inc |
3 Q |
$
-73.09 |
-903.04% |
- |
-213.14% |
Athira Pharma Inc |
1 Q |
$
-73.11 |
- |
- |
-118.64% |
Scilex Holding Company |
1 Q |
$
-74.51 |
-146.93% |
71.93% |
- |
Eiger Biopharmaceuticals Inc |
4 Q |
$
-74.96 |
-475.26% |
99.85% |
-869.84% |
Humacyte Inc |
1 Q |
$
-77.67 |
-402.37% |
99.24% |
- |
Metagenomi Inc |
1 Q |
$
-77.95 |
-172.21% |
- |
-32.05% |
Instil Bio Inc |
1 Q |
$
-78.03 |
-8023.79% |
- |
-45.52% |
Jasper Therapeutics Inc |
1 Q |
$
-78.78 |
- |
- |
-109.45% |
Sangamo Therapeutics Inc |
1 Q |
$
-79.45 |
-124.61% |
- |
-351.16% |
Surrozen Inc |
1 Q |
$
-81.70 |
- |
- |
- |
Tourmaline Bio Inc |
1 Q |
$
-82.87 |
- |
- |
-26.75% |
Vigil Neuroscience Inc |
4 Q |
$
-84.26 |
- |
- |
-96.5% |
Voyager Therapeutics Inc |
1 Q |
$
-84.69 |
-126.49% |
- |
-27.36% |
Aura Biosciences Inc |
4 Q |
$
-86.92 |
- |
- |
-47.83% |
Mesoblast Ltd |
2 Q |
$
-87.96 |
-1490.27% |
- |
-18.31% |
Taysha Gene Therapies Inc |
4 Q |
$
-89.30 |
-1071.62% |
- |
-110.57% |
Surface Oncology Inc |
2 Q |
$
-92.51 |
-297.82% |
- |
-111.71% |
Icosavax Inc |
3 Q |
$
-96.71 |
-16617.18% |
- |
-43.06% |
C4 Therapeutics Inc |
1 Q |
$
-103.28 |
-259.6% |
- |
-45.86% |
Fusion Pharmaceuticals Inc |
1 Q |
$
-104.28 |
-11534.96% |
- |
-48.74% |
Tarsus Pharmaceuticals Inc |
1 Q |
$
-104.94 |
-44.91% |
92.99% |
-39.72% |
Cg Oncology Inc |
1 Q |
$
-105.56 |
-15945.47% |
- |
-16.71% |
Lexeo Therapeutics Inc |
1 Q |
$
-109.31 |
- |
- |
-85.86% |
Tenaya Therapeutics Inc |
4 Q |
$
-111.13 |
- |
- |
-89.33% |
Valneva Se |
4 Q |
$
-113.60 |
-65.99% |
34.37% |
-79.09% |
Acumen Pharmaceuticals Inc |
1 Q |
$
-116.25 |
- |
- |
-58.24% |
Dbv Technologies S a |
1 Q |
$
-117.98 |
-2685.68% |
- |
-190.56% |
Point Of Care Nano technology Inc |
1 Q |
$
-118.40 |
- |
- |
- |
Vor Biopharma Inc |
1 Q |
$
-118.60 |
- |
- |
-142.13% |
Alector Inc |
1 Q |
$
-123.44 |
-139.74% |
- |
-100.58% |
Cabaletta Bio Inc |
1 Q |
$
-126.76 |
- |
- |
-78.29% |
Iteos Therapeutics Inc |
1 Q |
$
-130.81 |
-28.8% |
- |
-21.36% |
Coherus Biosciences inc |
1 Q |
$
-130.94 |
-66.3% |
56.65% |
- |
Tscan Therapeutics Inc |
1 Q |
$
-131.48 |
-2974.08% |
- |
-56.22% |
Ambrx Biopharma Inc |
3 Q |
$
-134.11 |
-1559.09% |
- |
-67.63% |
Solid Biosciences Inc |
1 Q |
$
-139.68 |
-944.71% |
- |
-70.55% |
Cidara Therapeutics Inc |
1 Q |
$
-141.00 |
-216.74% |
- |
-102.26% |
Adaptive Biotechnologies Corporation |
1 Q |
$
-141.89 |
-74.87% |
62.53% |
-66.17% |
Invivyd Inc |
1 Q |
$
-142.72 |
-389% |
- |
-165.23% |
Kyverna Therapeutics Inc |
1 Q |
$
-145.42 |
- |
- |
-51.62% |
Hillevax Inc |
4 Q |
$
-147.27 |
- |
- |
-75.27% |
Caribou Biosciences Inc |
1 Q |
$
-147.86 |
-1490.84% |
- |
-55.7% |
Adverum Biotechnologies Inc |
1 Q |
$
-153.16 |
-9554.52% |
- |
-149.69% |
Greenlight Biosciences Holdings Pbc |
1 Q |
$
-157.32 |
-1521% |
- |
-374.26% |
Regenxbio Inc |
1 Q |
$
-157.69 |
-100.62% |
78.12% |
-53.29% |
Arcellx Inc |
1 Q |
$
-162.42 |
-211.46% |
- |
-35.27% |
Tcr2 Therapeutics Inc |
1 Q |
$
-163.10 |
- |
- |
-97.81% |
Prokidney Corp |
1 Q |
$
-165.95 |
- |
- |
- |
Nanostring Technologies Inc |
3 Q |
$
-166.43 |
-102.44% |
35.72% |
- |
Meiragtx Holdings Plc |
1 Q |
$
-167.33 |
-484.9% |
- |
-241.89% |
Fate Therapeutics Inc |
1 Q |
$
-175.88 |
-1318.93% |
- |
-51.49% |
4d Molecular Therapeutics Inc |
1 Q |
$
-176.44 |
-767126.09% |
- |
-33.27% |
Cullinan Therapeutics Inc |
1 Q |
$
-178.74 |
- |
- |
-29.47% |
Kodiak Sciences Inc |
1 Q |
$
-190.63 |
- |
- |
-115.71% |
Twist Bioscience Corporation |
1 Q |
$
-191.15 |
-54.98% |
46.7% |
-41.11% |
Agenus Inc |
1 Q |
$
-195.19 |
-196.12% |
99.48% |
- |
Gritstone Bio Inc |
2 Q |
$
-201.00 |
-1375.84% |
- |
-496.33% |
Apogee Therapeutics Inc |
1 Q |
$
-205.39 |
- |
- |
- |
Sana Biotechnology Inc |
1 Q |
$
-208.67 |
- |
- |
-76.46% |
Cargo Therapeutics Inc |
1 Q |
$
-216.19 |
- |
- |
-58.44% |
Opthea Limited |
2 Q |
$
-220.24 |
-176665.73% |
- |
- |
Autolus Therapeutics Plc |
1 Q |
$
-238.13 |
-143453.61% |
- |
-52.82% |
Kymera Therapeutics Inc |
1 Q |
$
-240.88 |
-409.07% |
- |
-30.11% |
Sutro Biopharma Inc |
1 Q |
$
-245.22 |
-369.11% |
- |
-347.59% |
Replimune Group Inc |
1 Q |
$
-247.30 |
- |
- |
-57.98% |
Editas Medicine Inc |
1 Q |
$
-251.23 |
-701.04% |
- |
-166.29% |
Allogene Therapeutics Inc |
1 Q |
$
-252.32 |
-102155.06% |
- |
-56.5% |
Neumora Therapeutics Inc |
1 Q |
$
-258.06 |
- |
- |
-84.79% |
Scholar Rock Holding Corp |
1 Q |
$
-264.16 |
-558.47% |
- |
-118.22% |
Sorrento Therapeutics Inc |
2 Q |
$
-324.52 |
-636.01% |
95.53% |
- |
Relay Therapeutics Inc |
1 Q |
$
-333.39 |
-47969.21% |
- |
-44.16% |
Springworks Therapeutics Inc |
1 Q |
$
-348.02 |
- |
- |
-70.03% |
Iovance Biotherapeutics inc |
1 Q |
$
-375.36 |
-176.49% |
21.72% |
-49.71% |
Beam Therapeutics Inc |
4 Q |
$
-376.74 |
-593.13% |
- |
-45.77% |
Crispr Therapeutics Ag |
1 Q |
$
-385.66 |
-1023.64% |
- |
-20.08% |
Immunitybio inc |
1 Q |
$
-409.18 |
-1310.55% |
99.81% |
- |
Immunovant Inc |
1 Q |
$
-413.84 |
- |
- |
-80.6% |
Ginkgo Bioworks Holdings Inc |
1 Q |
$
-472.08 |
-198.84% |
80.41% |
-63.06% |
Prime Medicine Inc |
1 Q |
$
-495.41 |
- |
- |
-306.68% |
Vaxcyte Inc |
1 Q |
$
-509.63 |
- |
- |
-17.12% |
Recursion Pharmaceuticals Inc |
1 Q |
$
-574.78 |
-961.32% |
6.5% |
-74.7% |
Vir Biotechnology Inc |
1 Q |
$
-577.65 |
-2769.04% |
96.23% |
-47.46% |
Revolution Medicines Inc |
4 Q |
$
-600.09 |
-2033.52% |
- |
-33.45% |
Seagen Inc |
3 Q |
$
-750.23 |
-32.61% |
75.4% |
-28.06% |
Moderna Inc |
1 Q |
$
-3,357.00 |
-105.67% |
54.11% |
-30.1% |